2019 International Congress » Spasticity

1:45pm-3:15pm

AbobotulinumtoxinA: evidence for long duration of response

K. Foster, A. Lysandropoulos, P. Picaut (Abingdon, United Kingdom)

1:45pm-3:15pm

An examination of real-world onabotulinumtoxinA utilisation for the treatment of lower limb spasticity: The Adult Spasticity International Registry (ASPIRE) study

A. Esquenazi, W. Jost, G. Bavikatte, D. Bandari, M. Munin, A. Zuzek, A. Patel, J. Largent, G. Francisco (Elkins Park, PA, USA)

1:45pm-3:15pm

An examination of real-world onabotulinumtoxinA utilization for the treatment of upper limb spasticity: The Adult Spasticity International Registry (ASPIRE) study

G. Francisco, G. Bavikatte, W. Jost, D. Bandari, S. Tan Tang, A. Zuzek, A. Patel, J. Largent, A. Esquenazi (Taoyuan, Taiwan)

1:45pm-3:15pm

Associated movements disorders to Hereditary Spastic Paraplegia (HSP) in a case series from South Spain

A. Adarmes Gómez, S. Jesús Maestre, D. Macías García, C. Méndez Del-Barrio, R. Martin, F. Carrillo García, P. Gómez Garré, P. Mir Rivera (Seville, Spain)

1:45pm-3:15pm

Characterization of the motor phenotype and striatal muscle analysis in a mouse model of hereditary spasticity

A. Vignaud, C. Rivares, W. Noort, B. Koopmans, M. Loos, RT. Jaspers, M. Kalinichev (Les Ulis, France)

1:45pm-3:15pm

Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE

A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)

1:45pm-3:15pm

Comparative Study of Dry Needling under Ultrasound Guidance and Extracorporeal Shock Wave Therapy for Myofascial Pain and Spasticity Management

R. Bubnov, L. Kalika (Kyiv, Ukraine)

1:45pm-3:15pm

Goal setting for botulinum toxin injections: Impact of the Upper Limb International Spasticity (ULIS) programme

K. Fheodoroff, S. Ashford, J. Jacinto, A. Brashear, P. Maisonobe, A. Lysandropoulos, L. Turner-Stokes (Hermagor, Austria)

1:45pm-3:15pm

Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs in spastic hemiparesis: baseline data from the ENGAGE study

J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

1:45pm-3:15pm

Hereditary spastic paraplegia 11 is easy to be misdiagnosed as adult metachromatic leukodystrophy

S. Park, AR. Kim, N. Kim, WY. Park, JS. Kim, ES. Oh (Seoul, Republic of Korea)

1:45pm-3:15pm

Influence of the spinal manipulation on muscle spasticity: a randomized controlled trial

L. Shestopalova, T. Voloshyn (Truskavets, Ukraine)

1:45pm-3:15pm

Is teleneurology effective in screening for spasticity?

K. Harper, B. Eoff, F. Phibbs, D. Isaacs, S. Gallion, E. Thomas, J. Scott, M. Hacker, D. Charles (Nashville, TN, USA)

1:45pm-3:15pm

Natural History of Movement Abnormalities on Hereditary Spastic Paraplegia: validation of timed functional instruments

J. Saute, G. Machado, AP. Zanardi, V. Martins, D. Burguêz, L. Jacinto-Scudeiro, E. Monteiro, L. Peyré-Tartaruga (Porto Alegre, Brazil)

1:45pm-3:15pm

OnabotulinumtoxinA Reduces Disability in Treatment-Naive Adult Patients with Spasticity: Results from the ASPIRE Study

W. Jost, A. Ellenbogen, G. Wittenberg, K. Ngo, J. Largent, A. Zuzek, G. Francisco, A. Esquenazi (Irvine, CA, USA)

1:45pm-3:15pm

OnabotulinumtoxinA treatment in adults with spasticity reduces caregiver burden: Results from the ASPIRE study

A. Esquenazi, A. Ellenbogen, G. Wittenberg, K. Ngo, J. Largent, A. Zuzek, G. Francisco, W. Jost (Elkins Park, PA, USA)

1:45pm-3:15pm

Successful late rehabilitation based on botulinum therapy

T. Kuznetsova, A. Svetkina (Samara, Russian Federation)

1:45pm-3:15pm

The effect of Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs on voluntary movements in adults with spastic hemiparesis

J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)